Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study.
about
Piecing the puzzle together: Docetaxel cycles and current considerations in the treatment of metastatic castration-resistant prostate cancer.Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer.
P2860
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Association of Survival Benefi ...... nalysis of the Mainsail Study.
@en
Association of Survival Benefi ...... nalysis of the Mainsail Study.
@nl
type
label
Association of Survival Benefi ...... nalysis of the Mainsail Study.
@en
Association of Survival Benefi ...... nalysis of the Mainsail Study.
@nl
prefLabel
Association of Survival Benefi ...... nalysis of the Mainsail Study.
@en
Association of Survival Benefi ...... nalysis of the Mainsail Study.
@nl
P2093
P1433
P1476
Association of Survival Benefi ...... Analysis of the Mainsail Study
@en
P2093
Abderrahim Fandi
Aude Flechon
Cora N Sternberg
Daniel P Petrylak
Debora Barton
Ellen S de Morrée
Evgeny Kopyltsov
Jack Shiansong Li
Joaquim Bellmunt
John M Burke
P356
10.1001/JAMAONCOL.2016.3000
P577
2017-01-01T00:00:00Z